Bluebird Bio higher after FDA clears Zynteglo Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Bluebird Bio (BLUE) up 9% after FDA clearance of its Zynteglo therapy
- First Solar (FSLR) up 2% after Morgan Stanley upgraded its rating on the company, noting that the Inflation Reduction Act in the U.S. is a “big deal” for the clean tech sector
- NuScale Power (SMR) up 5% after being initiated with a Buy at Guggenheim
UP AFTER EARNINGS -
- Cisco Systems (CSCO) up 5%
- Keysight (KEYS) up 5%
- NetEase (NTES) up 3%
- Wolfspeed (WOLF) up 21%
- BJ’s Wholesale (BJ) up 7%
DOWN AFTER EARNINGS -
- Kohl's (KSS) down 9%
- Estee Lauder (EL) down 2%
- Tapestry (TPR) down 1%
- Analog Devices (ADI) down 5%
LOWER -
- Bed Bath & Beyond (BBBY) down 14% after Ryan Cohen's RC Ventures disclosed in a regulatory filing that it might sell as much as 7.78 million shares of the retailer
- Elanco Animal Health (ELAN) down 2% after Morgan Stanley cut the stock to Equal Weight from Overweight as visibility on the firm’s outlook remains weak
- Verizon (VZ) down 1% after MoffettNathanson downgraded the stock to Underperform
Symbols:
BLUE FSLR CSCO KEYS NTES WOLF BBBY ELAN BJ KSS SMR EL TPR ADI - $170.14 /
-9.045 (-5.05%)
VZ Keywords: Fly Intel, Wall Street, Top Stories, Stocks